Shares of Novo Nordisk (NVO) are on the rise on Wednesday following the drugmaker’s presentation of early-stage trial results for its experimental weight-loss pill, which seems to have impressed Wall Street analysts. BMO Capital says… To see the rest of the story go to thefly.com. (See Story Here):(https://www.thefly.com/permalinks/entry.php/id3981980/-Novo-Nordisk-rises-as-early-weightloss-pill-data-impresses-Street)
previous post
next post